Bhubaneswar: An advanced vaccine manufacturing unit would come up at Andharua, on the outskirt of Bhubaneswar.
Anchor developer Bharat Biotech Int Ltd (BBIL) will set up a ‘state of the art’ biotech incubation centre at Andharua which would produce ten types of vaccines including Malaria and Covid19 vaccine.
Chief Secretary Asit Tripathy on Friday directed the anchor developer Bharat Biotech Int Ltd (BBIL) to set up a ‘state of the art’ biotech incubation center, common facilities and IT corridor along with the first phase construction of the industry.
Tripathy directed to start the ground level construction work within a fortnight and commence production within the schedule time.
The company was requested to promote the local startups.
IDCO Chairman & Managing Director Sanjay Kumar Singh appraised, “The land is readily available at Biotech Park, Andharua for groundbreaking works. The building plan as per the design has also been approved.”
Science and Technology secretary Santosh Sarangi said, “In the meanwhile the required statutory clearances and pollution control board permission has been availed for setting up the unit.”
Presenting their preparedness, Chairman and Managing Director BBIL Dr Krishna Ella said, “Ours is a multidimensional biotechnology company specializing in manufacture of vaccines and bio-therapeutics. The company has taken up the development and production of new or improved vaccines against severe Rotavirus Diarrhea, Malaria, Japanese Encephalitis, Rabies, Pandemic Influenza and drug resistant Staphylococcus aureus.
Its unit at Andharua of Bhubaneswar would produce ten types of vaccines including malaria and covid vaccine. The total investment would be around Rs.300 cr. Best of the technology will be put in the unit.”
Chief Secretary Tripathy assured that the company would be provided all support for future expansion of the unit at Andharua.